News | May 03, 2025
Sanofi Consumer Healthcare India Q1 PAT up 12.9%
The Q1 2025 also witnessed a successful launch of Allegra D
The Q1 2025 also witnessed a successful launch of Allegra D
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
The unique soap-fusion of Gondhoraj lime and neem provides a refreshing skin-friendly experience
The stethoscope features high acoustic sensitivity and active noise cancellation, minimizing ambient interference to improve auscultation clarity, particularly in noisy hospital settings
Subcutaneous pembrolizumab administered every six weeks with a median injection time of two minutes, in combination with chemotherapy, shows consistent results across reported efficacy and safety endpoints compared to IV KEYTRUDA in combination with chemotherapy
EBITDA rose to Rs. 14.8 crore, marking a 16.5% y-o-y increase, while net profit surged to Rs. 6.4 crore
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
Bevqolva 25 mg/mL concentrate for infusion will be available in 4 mL (100 mg) and 16 mL (400 mg) single-use vials for infusion into veins
Performed within GENEWIZ from Azenta Life Sciences' CLIA-certified and CAP-accredited state-of-the-art clinical genomics laboratory
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
Subscribe To Our Newsletter & Stay Updated
